54 related articles for article (PubMed ID: 8302590)
1. In vitro reconstruction of tumour initiation in a human epithelium.
Bond JA; Wyllie FS; Rowson J; Radulescu A; Wynford-Thomas D
Oncogene; 1994 Jan; 9(1):281-90. PubMed ID: 8302590
[TBL] [Abstract][Full Text] [Related]
2. Novel Targeted Therapies for Metastatic Thyroid Cancer-A Comprehensive Review.
Al-Jundi M; Thakur S; Gubbi S; Klubo-Gwiezdzinska J
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751138
[TBL] [Abstract][Full Text] [Related]
3. Novel treatments for anaplastic thyroid carcinoma.
Ferrari SM; Elia G; Ragusa F; Ruffilli I; La Motta C; Paparo SR; Patrizio A; Vita R; Benvenga S; Materazzi G; Fallahi P; Antonelli A
Gland Surg; 2020 Jan; 9(Suppl 1):S28-S42. PubMed ID: 32055496
[TBL] [Abstract][Full Text] [Related]
4. Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Valvo V; Nucera C
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):37-59. PubMed ID: 30717910
[TBL] [Abstract][Full Text] [Related]
5. A Review of Driver Genetic Alterations in Thyroid Cancers.
Khatami F; Tavangar SM
Iran J Pathol; 2018; 13(2):125-135. PubMed ID: 30697281
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
Duquette M; Sadow PM; Husain A; Sims JN; Antonello ZA; Fischer AH; Song C; Castellanos-Rizaldos E; Makrigiorgos GM; Kurebayashi J; Nose V; Van Hummelen P; Bronson RT; Vinco M; Giordano TJ; Dias-Santagata D; Pandolfi PP; Nucera C
Oncotarget; 2015 Dec; 6(40):42445-67. PubMed ID: 26636651
[TBL] [Abstract][Full Text] [Related]
7. NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.
Jang EK; Song DE; Sim SY; Kwon H; Choi YM; Jeon MJ; Han JM; Kim WG; Kim TY; Shong YK; Kim WB
Thyroid; 2014 Aug; 24(8):1275-81. PubMed ID: 24820091
[TBL] [Abstract][Full Text] [Related]
8. Genetics and epigenetics of sporadic thyroid cancer.
Vu-Phan D; Koenig RJ
Mol Cell Endocrinol; 2014 Apr; 386(1-2):55-66. PubMed ID: 23933154
[TBL] [Abstract][Full Text] [Related]
9. RAS mutations in thyroid cancer.
Howell GM; Hodak SP; Yip L
Oncologist; 2013; 18(8):926-32. PubMed ID: 23873720
[TBL] [Abstract][Full Text] [Related]
10. Recent progress of genome study for anaplastic thyroid cancer.
Lee J; Hwang JA; Lee EK
Genomics Inform; 2013 Jun; 11(2):68-75. PubMed ID: 23843772
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis and mechanisms of thyroid cancer.
Xing M
Nat Rev Cancer; 2013 Mar; 13(3):184-99. PubMed ID: 23429735
[TBL] [Abstract][Full Text] [Related]
12. Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.
Xing M
Thyroid; 2010 Jul; 20(7):697-706. PubMed ID: 20578891
[TBL] [Abstract][Full Text] [Related]
13. RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.
Cassinelli G; Favini E; Degl'Innocenti D; Salvi A; De Petro G; Pierotti MA; Zunino F; Borrello MG; Lanzi C
Neoplasia; 2009 Jan; 11(1):10-21. PubMed ID: 19107227
[TBL] [Abstract][Full Text] [Related]
14. Role of epidermal growth factor receptor signaling in RAS-driven melanoma.
Bardeesy N; Kim M; Xu J; Kim RS; Shen Q; Bosenberg MW; Wong WH; Chin L
Mol Cell Biol; 2005 May; 25(10):4176-88. PubMed ID: 15870287
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Nikiforov YE
Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
[TBL] [Abstract][Full Text] [Related]
16. Nuclear envelope irregularity is induced by RET/PTC during interphase.
Fischer AH; Taysavang P; Jhiang SM
Am J Pathol; 2003 Sep; 163(3):1091-100. PubMed ID: 12937150
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells.
Jones CJ; Kipling D; Morris M; Hepburn P; Skinner J; Bounacer A; Wyllie FS; Ivan M; Bartek J; Wynford-Thomas D; Bond JA
Mol Cell Biol; 2000 Aug; 20(15):5690-9. PubMed ID: 10891505
[TBL] [Abstract][Full Text] [Related]
18. Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.
Bond JA; Haughton MF; Rowson JM; Smith PJ; Gire V; Wynford-Thomas D; Wyllie FS
Mol Cell Biol; 1999 Apr; 19(4):3103-14. PubMed ID: 10082577
[TBL] [Abstract][Full Text] [Related]
19. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.
Fischer AH; Bond JA; Taysavang P; Battles OE; Wynford-Thomas D
Am J Pathol; 1998 Nov; 153(5):1443-50. PubMed ID: 9811335
[TBL] [Abstract][Full Text] [Related]
20. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.
Owens LV; Xu L; Dent GA; Yang X; Sturge GC; Craven RJ; Cance WG
Ann Surg Oncol; 1996 Jan; 3(1):100-5. PubMed ID: 8770310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
